Adicet Bio Inc (ACET): Next-Year EPS Estimate 55.97%
As of 2026-06-11, Adicet Bio Inc (ACET) has a next-year EPS growth estimate of 55.97%.
On 2026-05-17, analyst consensus for ACET's next-year EPS growth shifted from 63.24% to 55.97% — a negative change of 7.27 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at 50.80%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 55.97%
- EPS growth this year
- 50.80%
- EPS next quarter (est)
- -$2.18
- Last price
- $7.55
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 55.97% | 50.80% | -$2.18 | $7.55 |
| 2026-06-10 | 55.97% | 50.80% | -$2.18 | $7.31 |
| 2026-06-09 | 55.97% | 50.80% | -$2.18 | $7.31 |
| 2026-06-08 | 55.97% | 50.80% | -$2.18 | $7.22 |
| 2026-06-07 | 55.97% | 50.80% | -$2.18 | $7.26 |
| 2026-06-04 | 55.97% | 50.80% | -$2.18 | $8.15 |
| 2026-06-03 | 55.97% | 50.80% | -$2.18 | $7.83 |
| 2026-06-02 | 55.97% | 50.80% | -$2.18 | $8.11 |
| 2026-06-01 | 55.97% | 50.80% | -$2.18 | $8.78 |
| 2026-05-31 | 55.97% | 50.80% | -$2.18 | $9.31 |
| 2026-05-28 | 55.97% | 50.80% | -$2.18 | $8.64 |
| 2026-05-27 | 55.97% | 50.80% | -$2.18 | $8.50 |
| 2026-05-26 | 55.97% | 50.80% | -$2.18 | $8.33 |
| 2026-05-25 | 55.97% | 50.80% | -$2.18 | $8.30 |
| 2026-05-24 | 55.97% | 50.80% | -$2.18 | $8.30 |
| 2026-05-21 | 55.97% | 50.80% | -$2.18 | $7.89 |
| 2026-05-20 | 55.97% | 50.80% | -$2.18 | $7.76 |
| 2026-05-19 | 55.97% | 50.80% | -$2.18 | $7.25 |
| 2026-05-18 | 55.97% | 50.80% | -$2.18 | $7.50 |
| 2026-05-17 | 55.97% | 50.80% | -$2.18 | $7.68 |
| 2026-05-14 | 63.24% | 50.67% | -$2.38 | $8.41 |
| 2026-05-13 | 66.16% | 41.82% | -$3.08 | $8.10 |
| 2026-05-12 | 66.16% | 41.82% | -$3.08 | $7.95 |
| 2026-05-11 | 66.16% | 41.82% | -$3.08 | $8.17 |
| 2026-05-10 | 66.16% | 41.82% | -$3.08 | $8.55 |
| 2026-05-07 | 66.16% | 41.82% | -$3.08 | $8.32 |
| 2026-05-06 | 66.16% | 41.82% | -$3.08 | $8.55 |
| 2026-05-05 | 66.16% | 41.82% | -$3.08 | $8.51 |
| 2026-05-04 | 78.37% | 41.73% | -$3.11 | $8.45 |
| 2026-05-03 | 78.37% | 41.73% | -$3.11 | $8.20 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Adicet Bio Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Adicet Bio Inc (ACET) has a next-year EPS growth estimate of 55.97%, based on analyst consensus.
When was the latest EPS estimate revision for ACET?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 63.24% to 55.97%.
What sector and industry does Adicet Bio Inc belong to?▾
Adicet Bio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ACET appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Adicet Bio Inc (ACET) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports